There are three main types of nanoparticles employed for anti-HIV therapeutics: polymeric nanoparticles, solid lipid nanoparticles, and inorganic nanoparticles. Solid lipid nanoparticles are sub-micron colloidal drug delivery systems ranging from 50-1000nm composed of physiological lipids that solidify upon dispersion in water or surfactant solutions. They offer properties like small size with large surface area, high drug loading capacity, and extended drug release due to slow degradation of lipid matrices. Figure 1 shows the solid lipid structure.